-
Dec.112023NEWS
HanAll Biopharma’s Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors
HanAll Biopharma’s Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP ..
-
Oct.262023NEWS
HanAll Biopharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
HanAll Biopharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
-
Oct.112023NEWS
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Initiate First-in-Human Phase 1 Clinical Study of HL192
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Initiate First-in-Human Phase 1..
-
Jul.282023NEWS
HanAll Biopharma Reports Second Quarter 2023 Financial Results and Provides a Business Update
HanAll Biopharma Reports Second Quarter 2023 Financial Results and Provides a Business Update
-
Jun.122023NEWS
HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Opportunities in Parkinson’s Disease
HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Oppo..
-
May.252023NEWS
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson’s Disease
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmac..